DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1Accord healthcare
03 1Apotex Inc
04 1Astellas Pharma
05 1Aurobindo Pharma Limited
06 1Baxter Healthcare Corporation
07 2GE Healthcare Inc
08 1GLAND PHARMA LIMITED
09 1Hikma Pharmaceuticals
10 1Hospira, Inc.
11 1IMS srl Micronizzazioni
12 1INDIES PHARMA
13 1Meitheal Pharmaceuticals
14 1Rapid Scan Pharma Solutions Europe Ltd.
15 1Rapidscan Pharma Solutions EU Ltd.
16 1Viatris
01 1Inj Solution
02 1Injection fluid, resolution
03 1SOLUTION FOR INJECTION
04 14SOLUTION;INTRAVENOUS
01 14RX
02 3Blank
01 1LEXISCAN
02 13REGADENOSON
03 3Rapiscan
01 1Norway
02 1Sweden
03 1Switzerland
04 14USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-04-11
Application Number : 213210
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-04-11
Application Number : 213236
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-04-11
Application Number : 207604
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LEXISCAN
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2008-04-10
Application Number : 22161
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-10-26
Application Number : 216437
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2023-05-23
Application Number : 217455
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2024-08-05
Application Number : 215955
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Switzerland
Brand Name : Rapiscan
Dosage Form : Inj Solution
Dosage Strength : 400mcg/5ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-07-12
Application Number : 207320
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2023-02-02
Application Number : 215827
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-08-31
Application Number : 214349
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-05-23
Application Number : 214252
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2022-04-11
Application Number : 212806
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2023-04-04
Application Number : 213856
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REGADENOSON
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 0.4MG/5ML (0.08MG/ML)
Packaging :
Approval Date : 2024-08-22
Application Number : 218054
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Sweden
Brand Name : Rapiscan
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 400 MICROGRAM / 5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Norway
Brand Name : Rapiscan
Dosage Form : Injection fluid, resolution
Dosage Strength : 400 mcg
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?